1. Adropin Inhibits Vascular Smooth Muscle Cell Osteogenic Differentiation to Alleviate Vascular Calcification via the JAK2/STAT3 Signaling Pathway
    Li Wang et al, 2022, BioMed Research International CrossRef
  2. The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
    Alexander A. Berezin et al, 2023, Biomedicines CrossRef